With the FLAIRstar module, diagnosing multiple sclerosis becomes faster, more accurate, and leads to quicker access to treatment.
Developed at NYU Abu Dhabi’s NYUAD Center for Brain and Health in collaboration with Cleveland Clinic Abu Dhabi, Yas Clinic–Khalifa City and Abu Dhabi Stem Cells Center, FLAIRstar is an AI-powered tool that makes MRI scans smarter by detecting the “central vein sign” (CVS), a highly specific biomarker for MS. This breakthrough helps doctors distinguish true MS lesions from look-alikes caused by other conditions such as migraines or vascular disease.
Osama Abdullah, PhD, MRI Physicist at the Center for Brain and Health, said:
“This is a perfect example of the ‘bench-to-bedside’ journey. Our work at NYUAD focuses on pushing the boundaries of what MRI can see. Partnering with the clinical expertise of Yas Clinic and ADSCC allows us to validate and apply these discoveries in a real-world setting, creating a powerful ecosystem for healthcare innovation right here in Abu Dhabi.”
Read more here
